Literature identifier | Study type | Test dosage | Effective dosage | Endocrine-mediated endpoints | Systems-level perturbations |
---|---|---|---|---|---|
PMID:10641015 | IVR | 100 mg/kg | 100 mg/kg | Decreased weights of epididymis | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg | 100 mg/kg | Decreased weights of seminal vesicles | Reproductive endocrine-mediated perturbations | |
PMID:11029267 | IVR | 3 mg/kg | - | No significant effects observed | - |
IVR | 6 mg/kg | - | No significant effects observed | - | |
IVR | 1 mg/kg | - | No significant effects observed | - | |
IVR | 200 mg/kg | 200 mg/kg | Changes in morphology of seminal vesicles | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Nipple retention | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Changes in epididymal morphology | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Alteration in prostate morphology | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Affects social behavior | Neurological endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Atrophy in seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Causes inflammation | Immunological endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Affects developmental process | Developmental endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Affects survival of live fetus | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Affects penis development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg | 200 mg/kg | Abnormal development of gonads in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 12 mg/kg | 12 mg/kg | Changes in number of nipples | Reproductive endocrine-mediated perturbations | |
PMID:12060841 | IVR | 200 mg/kg | 200 mg/kg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
PMID:12127262 | IVTH | 0.0001 M | 0.0001 M | Affects steroidogenesis | Reproductive endocrine-mediated perturbations |
IVTH | 0.0001 M | 0.0001 M | Oxidative stress in liver | Hepatic endocrine-mediated perturbations | |
PMID:14613717 | IVR | 250 mg/kg/day | 250 mg/kg/day | Affects xenobiotic metabolism | Metabolic endocrine-mediated perturbations |
PMID:14966743 | IVR | 200 mg/kg/day | 200 mg/kg/day | Affects testis development in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 200 mg/kg/day | 200 mg/kg/day | Undescended testes (or cryptorchidism) | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects locomotor activity | Neurological endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Alteration in vaginal morphology | Reproductive endocrine-mediated perturbations | |
PMID:15279874 | IVR | 100 mg/kg/day | 100 mg/kg/day | Affects sperm motility | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects survival of germ cells | Reproductive endocrine-mediated perturbations | |
PMID:15929892 | IVR | 6 mg/kg | 6 mg/kg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 3 mg/kg | 3 mg/kg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1.5 mg/kg | 1.5 mg/kg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 12 mg/kg | 12 mg/kg | Affects social behavior | Neurological endocrine-mediated perturbations | |
IVR | 12 mg/kg | 12 mg/kg | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
PMID:15933200 | IVR | 100 - 200 mg/kg | 100 - 200 mg/kg | Induce apoptosis of spermatogenic cells | Reproductive endocrine-mediated perturbations |
IVR | 100 - 200 mg/kg | 100 - 200 mg/kg | Reduced sperm counts in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 100 - 200 mg/kg | 100 - 200 mg/kg | Affects spermatogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 100 - 200 mg/kg | 100 - 200 mg/kg | Affects spermatogenesis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 100 - 200 mg/kg | 100 - 200 mg/kg | Affects fertility | Reproductive endocrine-mediated perturbations | |
PMID:16641540 | IVR | 3000 mg/kg/day | - | No significant effects observed | - |
IVR | 500 mg/kg/day | - | No significant effects observed | - | |
IVR | 6000 mg/kg/day | - | No significant effects observed | - | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Affects xenobiotic metabolism | Metabolic endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Decrease in T4 levels | Metabolic endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Decrease in T3 levels | Metabolic endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Changes in white blood cell (WBC) populations | Immunological endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Decreased weights of epididymis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Increased weights of pituitary gland | Neurological endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Increased weights of adrenal gland | Metabolic endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Changes in liver morphology | Hepatic endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Alteration in prostate morphology | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Increased liver weights in offspring | Developmental endocrine-mediated perturbations;Hepatic endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Decreased prostate weights in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Increased ovarian weights in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Alterations in preputial separation | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Hyperplasia in testis | Reproductive endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Increased weights of pituitary gland in offspring | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Decreased weights of epididymis | Reproductive endocrin | |
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Hyperplasia in ovary | ||
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Decreased weights of seminal vesicles in offspring | ||
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Decreased brain weights in offspring | ||
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Atrophy of seminal vesicles | ||
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Increased testis weights | ||
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Increased liver weights | ||
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Increased weights of adrenal gland in offspring | ||
IVR | 1000 mg/kg/day | 1000 mg/kg/day | Increased testis weights in offspring | ||
IVR | 200 mg/kg/day | 200 mg/kg/day | Decreased prostate weights in offspring | ||
IVR | 200 mg/kg/day | 200 mg/kg/day | Alterations in prepu | ||
IVR | 200 mg/kg/day | 200 mg/kg/day | |||
IVR | 200 mg/kg/day | 200 mg/kg/day | |||
IVR | 200 mg/kg/day | 200 mg/kg/day | |||
IVR | 200 mg/kg/day | 200 mg/kg/day | |||
IVR | 200 mg/kg/day | 200 mg/kg/day | |||
IVR | 200 mg/kg/day | 200 mg/kg/day | |||
IVR | 200 mg/kg/day | 200 mg/kg/day | |||
IVR | 40 mg/kg/day | 40 mg/kg/day | |||
IVR | 40 mg/kg/day | 40 mg/kg/day | |||
IVR | 40 mg/kg/day | 40 mg/kg/day | |||
PMID:16837734 | IVR | 100 mg/kg/day | 100 mg/kg/day | Affects survival of live fetus | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Reduced sperm counts | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects testicular morphology | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Changes in morphology of seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Induce apoptosis of spermatogenic cells | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects spermatogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects sperm motility | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects survival of germ cells | Reproductive endocrine-mediated perturbations | |
PMID:16962624 | IVTH | 0.000001 - 0.0003 M | 0.00003 - 0.0001 M | Increased estradiol levels | Reproductive endocrine-mediated perturbations |
IVTH | 0.000001 - 0.0003 M | 0.00003 - 0.0001 M | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVTH | 0.000001 - 0.0003 M | 0.00003 - 0.0001 M | Decreased progesterone levels | Reproductive endocrine-mediated perturbations | |
PMID:16973726 | IVR | 100 mg/kg/day | 100 mg/kg/day | Occurrence of mammary gland tumor | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects testicular function | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects spermatogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Increased cholesterol levels | Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Alteration in prostate morphology | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Induce apoptosis of spermatogenic cells | Reproductive endocrine-mediated perturbations | |
PMID:17905137 | IVR | 10 mg/kg/day | 10 mg/kg/day | Affects developmental process | Developmental endocrine-mediated perturbations |
PMID:18042343 | IVR | 100 mg/kg/day | 100 mg/kg/day | Affects testicular function | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects testicular morphology | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects survival of germ cells | Reproductive endocrine-mediated perturbations | |
PMID:18220299 | IVR | 100 mg/kg/day | 100 mg/kg/day | Affects prostate function | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased prostate weights | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects sperm motility | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Cancer phenotype | Endocrine-mediated cancer | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Reduced sperm counts | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects Wnt signaling pathway | Developmental endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Alteration in prostate morphology | Reproductive endocrine-mediated perturbations | |
PMID:18304984 | IVR | 100 mg/kg/day | 100 mg/kg/day | Affects neuronal signaling | Neurological endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Changes in morphology of pituitary gland | Neurological endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects uterine morphology | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Occurrence of mammary gland tumor | Endocrine-mediated cancer;Reproductive endocrine-mediated perturbations | |
PMID:18629315 | IVR | 100 mg/kg | 100 mg/kg | Affects expression of androgen receptor (AR) | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg | 100 mg/kg | Affects cytokine signaling | Immunological endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Induce cancer metastasis | Endocrine-mediated cancer | |
IVR | 100 mg/kg | 100 mg/kg | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Alterations in immune responses | Immunological endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Alteration in prostate morphology | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Decreased weights of seminal vesicles | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Decreased prostate weights | Reproductive endocrine-mediated perturbations | |
PMID:18940246 | IVR | 1 mg/kg | 1 mg/kg | Decreased prostate weights | Reproductive endocrine-mediated perturbations |
IVR | 1 mg/kg | 1 mg/kg | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
IVR | 1 mg/kg | 1 mg/kg | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
IVR | 1 mg/kg | 1 mg/kg | Reduced sperm counts | Reproductive endocrine-mediated perturbations | |
IVR | 1 mg/kg | 1 mg/kg | Abnormal sperm morphology | Reproductive endocrine-mediated perturbations | |
PMID:19672408 | IVR | 1 mg/kg/day | 1 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations |
IVR | 1 mg/kg/day | 1 mg/kg/day | Decreased weights of epididymis | Reproductive endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Increased FSH levels | Reproductive endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Decreased weights of seminal vesicles | Reproductive endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Decreased prostate weights | Reproductive endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Decreased weights of epididymis | Reproductive endocrine-mediated perturbations | |
IVR | 30 mg/kg/day | 30 mg/kg/day | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
PMID:19887539 | IVR | 50 mg/kg/day | 50 mg/kg/day | Epigenomic alterations in sperm | Reproductive endocrine-mediated perturbations |
PMID:20056826 | IVR | 100 mg/kg | 100 mg/kg | Abnormal sperm morphology | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg | 100 mg/kg | Affects survival of germ cells | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Prostate hyperplasia | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Affects anogenital distance | Reproductive endocrine-mediated perturbations | |
PMID:20566332 | IVR | 100 mg/kg | 100 mg/kg | Affects developmental process | Developmental endocrine-mediated perturbations |
PMID:20616205 | IVR | 30 mg/kg | 30 mg/kg | Affects fertility | Reproductive endocrine-mediated perturbations |
IVR | 30 mg/kg | 30 mg/kg | Alters sperm function | Reproductive endocrine-mediated perturbations | |
PMID:20927350 | IVR | 100 mg/kg/day | 100 mg/kg/day | Epigenomic alterations in sperm | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects embryonic development | Developmental endocrine-mediated perturbations | |
PMID:21172421 | IVR | 1 mg/kg/day | 1 mg/kg/day | Decreased testosterone levels | Reproductive endocrine-mediated perturbations |
IVR | 1 mg/kg/day | 1 mg/kg/day | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
IVR | 1 mg/kg/day | 1 mg/kg/day | Affects gametogenesis | Reproductive endocrine-mediated perturbations | |
PMID:21636974 | IVR | 100 mg/kg/day | 100 mg/kg/day | Affects spermatogenesis | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects sperm motility | Reproductive endocrine-mediated perturbations | |
PMID:22285353 | IVR | 100 mg/kg | 100 mg/kg | Affects steroidogenesis | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg | 100 mg/kg | Increased liver weights | Hepatic endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Affects expression of estrogen receptor-alpha (ER-alpha) | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Increased weights of adrenal gland | Metabolic endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Reduced sperm counts | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Decreased androstenedione levels | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Affects the normal functioning of reproductive system | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Increased estrone levels | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Increased uterine weights | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Decreased ovarian weights | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Decreased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Increased LH levels | Reproductive endocrine-mediated perturbations | |
PMID:23041264 | IVR | 100 mg/kg/day | 100 mg/kg/day | Abnormal sperm morphology | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Changes in ovarian morphology | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Changes in ovarian morphology | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects survival of germ cells | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Changes in morphology of seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Changes in ovarian morphology of offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Changes in morphology of seminiferous tubules | Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects survival of germ cells | Reproductive endocrine-mediated perturbations | |
PMID:23160963 | IVR | 1 mg/kg/day | 1 mg/kg/day | Affects carbohydrates metabolism | Metabolic endocrine-mediated perturbations |
IVR | 1 mg/kg/day | 1 mg/kg/day | Affects steroidogenesis | Reproductive endocrine-mediated perturbations | |
PMID:25051444 | IVR | 100 mg/kg/day | 100 mg/kg/day | Affects social behavior | Neurological endocrine-mediated perturbations |
PMID:25324206 | IVTH | 0.00003 M | 0.00003 M | Cancer phenotype | Endocrine-mediated cancer |
IVTH | 0.00003 M | 0.00003 M | Affects androgen signaling | Reproductive endocrine-mediated perturbations | |
IVTH | 0.0000003 M | - | No significant effects observed | - | |
IVTH | 0.000003 M | 0.000003 M | Affects androgen signaling | Reproductive endocrine-mediated perturbations | |
IVTH | 0.000001 M | 0.000001 M | Affects androgen signaling | Reproductive endocrine-mediated perturbations | |
IVTH | 0.00001 M | 0.00001 M | Cancer phenotype | Endocrine-mediated cancer | |
IVTH | 0.00001 M | 0.00001 M | Affects androgen signaling | Reproductive endocrine-mediated perturbations | |
PMID:25784924 | IVR | 100 mg/kg | 100 mg/kg | Affects developmental process | Developmental endocrine-mediated perturbations |
IVR | 100 mg/kg | 100 mg/kg | Affects neural development | Developmental endocrine-mediated perturbations;Neurological endocrine-mediated perturbations | |
PMID:25853433 | IVR | 100 mg/kg/day | 100 mg/kg/day | Alters mammary gland development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
PMID:25897752 | IVR | 1 mg/kg | 1 mg/kg | Affects differentiation process | Developmental endocrine-mediated perturbations |
IVR | 100 mg/kg | 100 mg/kg | Affects differentiation process | Developmental endocrine-mediated perturbations | |
PMID:25929820 | IVR | 150 mg/kg/day | 150 mg/kg/day | Pregnancy complications | Reproductive endocrine-mediated perturbations |
IVR | 150 mg/kg/day | 150 mg/kg/day | Increase in estradiol/testosterone ratio | Reproductive endocrine-mediated perturbations | |
PMID:27684650 | IVTH | 0.00000001 - 0.000001 M | 0.00000001 - 0.000001 M | Affects developmental process | Developmental endocrine-mediated perturbations |
PMID:27992467 | IVR | 100 mg/kg/day | 100 mg/kg/day | Affects developmental process | Developmental endocrine-mediated perturbations |
PMID:29668838 | IVR | 300 mg/kg | 300 mg/kg | Hypospadias | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
IVR | 300 mg/kg | 300 mg/kg | Affects penis development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 150 mg/kg | 150 mg/kg | Affects penis development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 150 mg/kg | 150 mg/kg | Hypospadias | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Hypospadias | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 75 mg/kg | 75 mg/kg | Affects penis development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 75 mg/kg | 75 mg/kg | Hypospadias | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 100 mg/kg | 100 mg/kg | Affects penis development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 600 mg/kg | 600 mg/kg | Hypospadias | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 125 mg/kg | 125 mg/kg | Hypospadias | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 125 mg/kg | 125 mg/kg | Affects penis development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
PMID:30212226 | IVR | 1 mg/kg | 1 mg/kg | Decreased estradiol levels in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
PMID:30444163 | IVR | 1 mg/kg | 1 mg/kg | Abnormal sperm morphology | Reproductive endocrine-mediated perturbations |
IVR | 1 mg/kg | 1 mg/kg | Affects social behavior | Neurological endocrine-mediated perturbations | |
IVR | 1 mg/kg | 1 mg/kg | Alters sperm function | Reproductive endocrine-mediated perturbations | |
PMID:31491443 | IVR | 1 mg/kg | 1 mg/kg | Affects expression of androgen receptor (AR) | Reproductive endocrine-mediated perturbations |
PMID:7974495 | IVR | 100 mg/kg/day | 100 mg/kg/day | Changes in epididymal morphology | Reproductive endocrine-mediated perturbations |
IVR | 100 mg/kg/day | 100 mg/kg/day | Affects development of reproductive system | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects development of reproductive system | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Changes in epididymal morphology | Reproductive endocrine-mediated perturbations | |
PMID:9007049 | IVR | 200 mg/kg/day | 200 mg/kg/day | Increased prostate weights | Reproductive endocrine-mediated perturbations |
IVR | 200 mg/kg/day | 200 mg/kg/day | Affects sexual behavior | Neurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Increased testosterone levels | Reproductive endocrine-mediated perturbations | |
IVR | 200 mg/kg/day | 200 mg/kg/day | Increased weights of seminal vesicles | Reproductive endocrine-mediated perturbations |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.